WASHINGTON, D.C. - A recent study of the Severe Acute Respiratory Syndrome (SARS) epidemic in Toronto revealed that 77 percent of the 144 observed patients acquired SARS in a nosocomial environment, according to Barry Farr, MD, MSc, speaking at the recent 30th annual conference of the Association for Professionals in Infection Control and Epidemiology (APIC). The same study also indicated that 51 percentof all SARS patients were healthcare workers.
"This study clearly emphasizes the vulnerability of hospital environments to new outbreaks and the need to exercise full-time infection control surveillance," said Farr, the William S. Jordan Jr. Professor of Medicine and Epidemiology at the University of Virginia (UVA) and hospital epidemiologist of the UVA Health System. Farr spoke at the conference during the first-ever State of the Science Lecture sponsored by the APIC Research Foundation.
Farr noted that with the threat of bioterrorism and the onset of new viruses that can be borne across the globe in literally hours, infection control professionals will play an increasingly important role in helping to prevent and limit infections in nosocomial environments. Farr is the former president of the Society for Healthcare Epidemiology of America (SHEA) and now serves as editor of the SHEA journal, Infection Control and Hospital Epidemiology.
According to Barbara Russell, president of the research foundation and head of infection control at Baptist Hospital of Miami, "Hospital-transmitted infections are a serious concern in highly developed as well as emerging nations. In the U.S., more than 80,000 patients die of infection-related deaths every year, and over two million non-fatal infection cases are reported." She added that measures employed by infection control professionals have proven to be the most effective and cost-efficient means to reduce the risk of contagion in health care facilities.
The APIC Research Foundation is committed to improving the quality, value, and cost-effectiveness of health care by supporting research aimed at preventing health care associated complications, and evaluating the efficacy of infection prevention practices.
The Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) is a non-profit, international organization that seeks to influence, support and improve the quality of health care through the practice and management of infection control. Based in Washington, D.C., APIC (www.apic.org) has more than 110 regional chapters in the U.S. and more than 12,000 members worldwide.
Source: APIC
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.